Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Wolf
H H
HH
Department of Internal Medicine, University of Düsseldorf, F.R.G.
Scharf
R E
RE
Arning
M
M
Schneider
W
W
D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000150:complications; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008111:Liver Function Tests; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D017964:Itraconazole; D005437:Flucytosine; D007654:Ketoconazole